PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) FOR IMPROVED SURVIVAL WITH SECOND-LINE TREATMENT OPTIONS, IN PATIENTS WITH METASTATIC HORMONEREFRACTORY PROSTATE CANCER (MHRPC) PREVIOUSLY TREATED WITH DOCETAXEL

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71914-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)71914-3/fulltext
Title : PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS) FOR IMPROVED SURVIVAL WITH SECOND-LINE TREATMENT OPTIONS, IN PATIENTS WITH METASTATIC HORMONEREFRACTORY PROSTATE CANCER (MHRPC) PREVIOUSLY TREATED WITH DOCETAXEL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71914-3&doi=10.1016/S1098-3015(11)71914-3
First page : A254
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 76
Categories :
Tags :
Regions :
ViH Article Tags :